glp 1 vs sglt2 Benefits of treatment with SGLT2i and GLP-1RA based on their direct and Summary of cardiovascular outcome trials
Description
The insulin-sensitizing and glucose-lowering properties of GLP-1 agonists make them a first-line consideration for anyone in the diabetes spectrum
Session Information Date: Sunday, October 26, 2025 Title: (04300469) Rheumatoid Arthritis Diagnosis, Manifestations, and Outcomes Poster I Session Type: Poster Session A Session Time: 10:30AM-12:30PM Background/Purpose: Obesity significantly increases cardiovascular morbidity and mortality in rheumatoid arthritis (RA), yet effective strategies for managing obesity-related risks in this population remain limited
A greater number of people aged 60 years or older met at least one exclusion criterion vs
Many patients have tried other weight loss programs with little progress, which makes them unsure whether a new program will deliver real results
Nassar, M., Nassar, O., Abosheaishaa, H
Epigenetic alterations in immune cells of systemic Lupus erythematosus and therapeutic implications
